Literature DB >> 1949424

The effect of impaired lipid metabolism on the smooth muscle cells of rabbits.

K P Jünemann1, J Aufenanger, T Konrad, J Pill, B Berle, C Persson-Jünemann, P Alken.   

Abstract

Our clinical data enabled us to demonstrate a correlation between impaired lipid metabolism and vasculogenic impotent men. Our aim was to evaluate the effect of an impaired lipid metabolism on the smooth muscle of the corpus cavernosum. A total of 16 rabbits were given a cholesterol-enriched diet for 3 months, and 8 of these received additional thromboxane A2 receptor antagonist; 10 other rabbits (control) were fed a normal diet. Subsequently, cavernous tissue biopsies were taken, and tissue lipid extractions and electron microscopic evaluation were made from 3 rabbits in each group. In the untreated high-cholesterol diet group, cholesterol levels reached approx. 2.1 micrograms/mg body weight compared with 1.07 micrograms/mg b.wt. in the thromboxane A2 receptor antagonist-treated group and elevated levels compared with control group. Similar results were found for the triglyceride and free fatty acid levels. Lecithin tissue levels in treated rabbits were distinctly elevated against those of other 2 groups. Ultramorphological examination of the control group disclosed normal smooth muscle cell (SMC) architecture with numerous sites of intercellular contacts. These findings contrasted with those of the high-cholesterol diet groups which showed significant SMC degeneration with loss of intercellular contacts. Our data imply that impaired lipid metabolism causes cavernous SMC degeneration which plays a major role in the pathogenesis of erectile dysfunction. The thromboxane A2 receptor antagonist seems to produce a protective metabolic effect on the erectile tissue which may have some consequences future treatment strategies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949424     DOI: 10.1007/bf00299056

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  9 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Impotence and diabetes mellitus.

Authors:  A RUBIN; D BABBOTT
Journal:  J Am Med Assoc       Date:  1958-10-04

Review 3.  Pathophysiology of erectile dysfunction.

Authors:  K P Jünemann; C Persson-Jünemann; P Alken
Journal:  Semin Urol       Date:  1990-05

4.  Further evidence of venous outflow restriction during erection.

Authors:  K P Juenemann; J A Luo; T F Lue; E A Tanagho
Journal:  Br J Urol       Date:  1986-06

5.  Hemodynamics of erection in the monkey.

Authors:  T F Lue; T Takamura; R A Schmidt; A J Palubinskas; E A Tanagho
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

6.  Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration.

Authors:  G R Fournier; K P Juenemann; T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

7.  Diagnostic evaluation, classification, and treatment of men with sexual dysfunction.

Authors:  D K Montague; R E James; V G deWolfe; L M Martin
Journal:  Urology       Date:  1979-12       Impact factor: 2.649

8.  Correlation of altered penile ultrastructure with clinical arterial evaluation.

Authors:  C Persson; W Diederichs; T F Lue; T S Yen; I J Fishman; P H McLin; E A Tanagho
Journal:  J Urol       Date:  1989-12       Impact factor: 7.450

9.  Architecture and nerve supply of mammalian smooth muscle tissue.

Authors:  R CAESAR; G A EDWARDS; H RUSKA
Journal:  J Biophys Biochem Cytol       Date:  1957-11-25
  9 in total
  5 in total

Review 1.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

Review 2.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Is apolipoprotein-(a) an important indicator of vasculogenic erectile dysfunction?

Authors:  O Atahan; O Kayigil; N Hizel; A Metin
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 4.  Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator.

Authors:  H Solomon; J W Man; G Jackson
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

5.  Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction.

Authors:  M Tolga Dogru; M Murad Basar
Journal:  Int Urol Nephrol       Date:  2009-10-29       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.